Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wysoczynski M et al. – The authors noticed that such RMS cells, if injected into skeletal muscles of immunodeficient mice, have a reduced ability for tumor formation. They conclude that IL–8 is a pivotal proangiogenic factor released by human RMS cells in hypoxic conditions and that the targeting of IL–8 may prove to be a novel and efficient strategy for inhibiting RMS growth.

Related Articles

Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells
British Journal of Cancer, 11/06/09    Relevance Score: 87%

Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma
European Journal of Cancer, 10/01/09    Relevance Score: 87%

A rare case of paratesticular pleomorphic rhabdomyosarcoma diagnosed by fine needle aspiration: A case report
Diagnostic Cytopathology, 10/02/09    Relevance Score: 85%

Laparoscopic Retroperitoneal Lymph Node Dissection for High-Risk Pediatric Patients with Paratesticular Rhabdomyosarcoma
Journal of Endourology, 10/27/09    Relevance Score: 83%

First Case Report of Bilateral Metastatic Intratesticular Rhabdomyosarcoma
Urology, 10/26/09    Relevance Score: 83%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address